A large meal overwhelms an already slow digestive system, causing severe bloating, nausea, and discomfort
Hypoglycemia: As a GLP-1 receptor agonist, Semaglutide can stimulate insulin secretion, potentially leading to hypoglycemia, especially when used in combination with other glucose-lowering medications or in individuals with impaired kidney function
Ethics declarations Conflict of interest During the peer review process the manufacturer of the agent under review was offered an opportunity to comment on the article
Consult your healthcare professional to discuss the pros and cons of these treatment options, your health goals, and preferences to make an informed decision.
Its unique mechanism of action complements existing treatments, providing an additional avenue for managing hypertension